Streptococcal IdeS: therapeutic potential for Guillain–Barré syndrome

Plasma exchange and intravenous immunoglobulin are effective in treating Guillain–Barré syndrome (GBS) probably because the former removes IgG autoantibodies and complement and the latter inhibits complement activation subsequent to the autoantibody binding to peripheral nerve antigens. IgG degradin...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Ryo, Yuki, Nobuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508529/
https://www.ncbi.nlm.nih.gov/pubmed/26194472
http://dx.doi.org/10.1038/srep10809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508529/
https://www.ncbi.nlm.nih.gov/pubmed/26194472
http://dx.doi.org/10.1038/srep10809

Ejemplares similares